NanoBioMaterials by Bhupinder Singh - ISBN: 9780815399780
Hardcover
The present book volume presents a holistic view of the aspects of nanobiomaterials incl. their stellar merits and limitations, applications in diverse fields, their futuristic promise in the fields of biomedical science and drug delivery. The federal & regulatory issues on the usage of nanobiom…

NanoBioMaterials

$638.03

  • Hardcover

    288 pages

  • Release Date

    24 July 2018

Check Delivery Options

Summary

The present book volume presents a holistic view of the aspects of nanobiomaterials incl. their stellar merits and limitations, applications in diverse fields, their futuristic promise in the fields of biomedical science and drug delivery. The federal & regulatory issues on the usage of nanobiomaterials have been assigned due consideration.

Book Details

ISBN-13:9780815399780
ISBN-10:0815399782
Author:Bhupinder Singh
Publisher:Taylor & Francis Inc
Imprint:CRC Press Inc
Format:Hardcover
Number of Pages:288
Release Date:24 July 2018
Weight:795g
Dimensions:178mm x 254mm
A-Format
B-Format
C-Format
NanoBioMaterials by Bhupinder Singh - ISBN: 9780815399780
178 × 254 mm
A4
mm / in
About The Author

Bhupinder Singh

Acclaimed globally for his QbD-based development of novel and nanostructured drug delivery, computational pharmaceutics, advanced pharmacokinetic modelling, Professor Bhupinder Singh Bhoop has contributed over three decades of dedicated service towards Pharmaceutical Education and Research. He has to his credit over 300 publications in peer-reviewed journals including 16 books and 52 book chapters. A widely travelled scientist, he has delivered more than 290 plenary, keynote and invited talks in India and overseas, including in USA, Canada, UK, Germany, China, Thailand, Hong Kong, Kuwait and Bangladesh. He has been conferred with numerous global and national awards. Over a thousand of industrial scientists from leading pharma companies of India, of the likes of Mylan, Zydus, Ranbaxy, Cipla, Cadila Pharma, Sentiss, Sun Pharma, IPCA, Glenmark, Sanofi-Aventis, Ajanta, Alkem, Bharat Serums, Panacea Biotec and Beximco Pharma (Dhaka) have been duly trained by him on QbD and Biowaivers. He has guided/guiding 31 doctoral, 54 postgraduate, and 6 post-doctoral research projects, completed 6 industrial consultancy assignments, has 5 patents (1 granted), and is involved in tech. transfer of two nano-based drug delivery products.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.